A Defective Circulating Mitochondrial Bioenergetics Profile Reflects the Hepatic One and Outlines Genetic MASLD
Genetics and mitochondrial (mt) dysfunction contribute to metabolic dysfunction-associated steatotic liver disease (MASLD). Recently, we demonstrated that the co-presence of <i>PNPLA3</i>, <i>TM6SF2</i> and <i>MBOAT7</i> polymorphisms predisposes to disease progre...
Saved in:
| Main Authors: | Erika Paolini, Miriam Longo, Marica Meroni, Paola Podini, Marco Maggioni, Angelo Quattrini, Anna Ludovica Fracanzani, Paola Dongiovanni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/14/6/618 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach
by: Marica Meroni, et al.
Published: (2025-02-01) -
A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism
by: Grace E. Shryack, et al.
Published: (2025-06-01) -
Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
by: Hala Saeed Jaara, et al.
Published: (2024-12-01) -
Refining the Role of EGR1 as a Biomarker in MASLD [Letter]
by: Zeng X
Published: (2025-02-01) -
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
by: Lara Gibellini, et al.
Published: (2020-11-01)